Advertisement

Treating Medical Comorbidities Associated with Dementia Among Latinos

  • Samuel C. GableEmail author
  • Maureen K. O’Connor
Chapter
  • 8 Downloads

Abstract

Latinos in the United States (U.S.) experience greater prevalence and worse course for certain health conditions associated with dementia when compared to the general population. Close scrutiny of these discrepancies is crucial in order to improve the early and accurate detection of neurodegenerative processes, as well as intervene in potentially treatable causes of cognitive decline. Such scrutiny involves the examination of biological and sociocultural contributors of medical comorbidities among different Latino subgroups, with the largest U.S.-residing populations being Mexican Americans and Caribbean Latinos. This chapter will review the medical comorbidities most often associated with dementia and cognitive decline as they pertain to Latinos in the U.S., including type 2 diabetes mellitus (T2DM), thyroid disease, infectious diseases (i.e., HIV, hepatitis C), obstructive sleep apnea (OSA), depression, alcohol abuse, and nutritional deficiencies (i.e., vitamin B12, folate). Following this section, the four major dementias are reviewed with an emphasis on the prevalence, genetics, pathology, and clinical presentation for Latino populations: Alzheimer’s disease (AD), vascular dementia (VaD), frontotemporal lobar degeneration (FTLD), and Lewy body dementias (LBD), including dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD).

Keywords

Dementia Health Disparities Hispanics Latinos Medical Comorbidities 

Notes

Summary

Latinos are a diverse, large minority population within the U.S. with unique trends in dementia and medical comorbidities. In particular, a higher rate of metabolic and vascular disorders places Latinos at a greater risk for cerebrovascular burden, which in turn is likely to influence the prevalence of Alzheimer’s disease and vascular dementia in particular. Continued research is necessary to further understand the specific genetic contributors of populations originating from Latin America in regard to dementia prevalence and course, as well as medical comorbidities. Important differences in social/cultural and biological variables exist between particular subgroups of Latinos, with the major divisions considered in the literature being between Latinos of Mexican or Caribbean origin. Socioeconomic variables such as poverty, access to quality healthcare, educational history, immigration history, English-language acquisition, and acculturation to the U.S. society are also important considerations in clinical practice when working with elderly Latinos in the context of neurodegenerative diseases and medical comorbidities.

References

  1. Aarsland, D., Perry, R., Larsen, J. P., McKeith, I. G., O’Brien, J. T., Perry, E. K., … Ballard, C. G. (2005). Neuroleptic sensitivity in Parkinson’s disease and parkinsonian dementias. The Journal of Clinical Psychiatry, 66(5), 633–637.CrossRefGoogle Scholar
  2. Alhola, P., & Polo-Kantola, P. (2007). Sleep deprivation: Impact on cognitive performance. Neuropsychiatric Disease and Treatment, 3(5), 553–567.PubMedPubMedCentralGoogle Scholar
  3. Allen, L. H. (2008). Causes of vitamin B12 and folate deficiency. Food and Nutrition Bulletin, 29(2 Suppl), S20–S34; discussion S35–37.  https://doi.org/10.1177/15648265080292S105CrossRefPubMedGoogle Scholar
  4. Allen, L. H. (2009). How common is vitamin B-12 deficiency? The American Journal of Clinical Nutrition, 89(2), 693S–696S.  https://doi.org/10.3945/ajcn.2008.26947ACrossRefPubMedGoogle Scholar
  5. Alvarez, J., Jason, L. A., Olson, B. D., Ferrari, J. R., & Davis, M. I. (2007). Substance abuse prevalence and treatment among Latinos and Latinas. Journal of Ethnicity in Substance Abuse, 6(2), 115–141.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Alzheimer’s Association. (2016). 2016 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 12(4), 459–509.CrossRefGoogle Scholar
  7. Barnes, D. E., & Yaffe, K. (2011). The projected effect of risk factor reduction on Alzheimer’s disease prevalence. The Lancet. Neurology, 10(9), 819–828.  https://doi.org/10.1016/S1474-4422(11)70072-2CrossRefPubMedPubMedCentralGoogle Scholar
  8. Bégin, M. E., Langlois, M. F., Lorrain, D., & Cunnane, S. C. (2008). Thyroid function and cognition during aging. Current Gerontology and Geriatrics Research, 2008, 1–11.  https://doi.org/10.1155/2008/474868CrossRefGoogle Scholar
  9. Bernardin, F., Maheut-Bosser, A., & Paille, F. (2014). Cognitive impairments in alcohol- dependent subjects. Frontiers in Psychiatry, 5.  https://doi.org/10.3389/fpsyt.2014.00078
  10. Blessman, D. J. (2008). Chronic hepatitis C in the Hispanic/Latino population living in the United States: A literature review. Gastroenterology Nursing: The Official Journal of the Society of Gastroenterology Nurses and Associates, 31(1), 17–25.  https://doi.org/10.1097/01.SGA.0000310931.64854.5fCrossRefGoogle Scholar
  11. Bordier, L., Doucet, J., Boudet, J., & Bauduceau, B. (2014). Update on cognitive decline and dementia in elderly patients with diabetes. Diabetes & Metabolism, 40(5), 331–337.  https://doi.org/10.1016/j.diabet.2014.02.002CrossRefGoogle Scholar
  12. Campos, M., Edland, S. D., & Peavy, G. M. (2013). Exploratory study of apolipoprotein E ε4 genotype and risk of Alzheimer’s disease in Mexican Hispanics. Journal of the American Geriatrics Society, 61(6), 1038–1040.  https://doi.org/10.1111/jgs.12292CrossRefPubMedPubMedCentralGoogle Scholar
  13. Centers for Disease Control and Prevention [CDC]. (2016). HIV among people aged 50 and over. Retrieved from https://www.cdc.gov/hiv/group/age/olderamericans/index.html
  14. Centers for Disease Control and Prevention [CDC]. (2017). HIV among Latinos. Retrieved from https://www.cdc.gov/hiv/group/racialethnic/hispaniclatinos/index.html
  15. Chavez-Dueñas, N. Y., Adames, H. Y., & Organista, K. C. (2014). Skin-color prejudice and within-group racial discrimination: Historical and current impact on Latino/a populations. Hispanic Journal of Behavioral Sciences, 36(1), 3–26.  https://doi.org/10.1177/0739986313511306CrossRefGoogle Scholar
  16. Chin, A. L., Negash, S., & Hamilton, R. (2011). Diversity and disparity in dementia: The impact of ethnoracial differences in Alzheimer’s disease. Alzheimer Disease & Associated Disorders, 25(3), 187–195.  https://doi.org/10.1097/WAD.0b013e318211c6c9CrossRefGoogle Scholar
  17. Claessens, D., Geijselaers, S. L. C., & Sep, S. J. S. (2016). Glycaemia, cognition, and type 2 diabetes. MaRBLe, 2(0). Retrieved from http://openjournals.maastrichtuniversity.nl/Marble/article/view/296
  18. Clark, C. M., DeCarli, C., Mungas, D., Chui, H. I., Higdon, R., Nuñez, J., … van Belle, G. (2005). Earlier onset of Alzheimer disease symptoms in latino individuals compared with anglo individuals. Archives of Neurology, 62(5), 774–778.  https://doi.org/10.1001/archneur.62.5.774CrossRefPubMedGoogle Scholar
  19. Clark, H., Surendera Babu, A., Harris, S., & Hardnett, F. (2015). HIV-related mortality among adults (≥18 years) of various Hispanic or Latino subgroups—United States, 2006–2010. Journal of Racial and Ethnic Health Disparities, 2(1), 53–61.  https://doi.org/10.1007/s40615-014-0047-xCrossRefPubMedGoogle Scholar
  20. Cohen, R. A., Boland, R., Paul, R., Tashima, K. T., Schoenbaum, E. E., Celentano, D. D., … Carpenter, C. C. (2001). Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS (London, England), 15(3), 341–345.CrossRefGoogle Scholar
  21. Cox, D. J., Kovatchev, B. P., Gonder-Frederick, L. A., Summers, K. H., McCall, A., Grimm, K. J., & Clarke, W. L. (2005). Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care, 28(1), 71–77.CrossRefGoogle Scholar
  22. Crimmins, E. M., Kim, J. K., Alley, D. E., Karlamangla, A., & Seeman, T. (2007). Hispanic paradox in biological risk profiles. American Journal of Public Health, 97(7), 1305–1310.  https://doi.org/10.2105/AJPH.2006.091892CrossRefPubMedPubMedCentralGoogle Scholar
  23. Cummins, C. A., Erlyana, E., Fisher, D. G., & Reynolds, G. L. (2015). Hepatitis C infection among Hispanics in California. Journal of Addictive Diseases, 34(4), 263–273.  https://doi.org/10.1080/10550887.2015.1074500CrossRefPubMedPubMedCentralGoogle Scholar
  24. Cysique, L. A. J., Maruff, P., & Brew, B. J. (2006). Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology, 66(9), 1447–1450.  https://doi.org/10.1212/01.wnl.0000210477.63851.d3CrossRefPubMedGoogle Scholar
  25. Daviglus, M. L., Talavera, G. A., Avilés-Santa, M. L., Allison, M., Cai, J., Criqui, M. H., … Stamler, J. (2012). Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA, 308(17), 1775–1784.  https://doi.org/10.1001/jama.2012.14517CrossRefPubMedPubMedCentralGoogle Scholar
  26. Davis, J. D., & Tremont, G. (2007). Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinologica, 32(1), 49–65.PubMedGoogle Scholar
  27. de Benoist, B. (2008). Conclusions of a WHO technical consultation on folate and vitamin B12 deficiencies. Food and Nutrition Bulletin, 29(2 Suppl), S238–S244.  https://doi.org/10.1177/15648265080292S129CrossRefPubMedGoogle Scholar
  28. Deramecourt, V., Slade, J. Y., Oakley, A. E., Perry, R. H., Ince, P. G., Maurage, C.-A., & Kalaria, R. N. (2012). Staging and natural history of cerebrovascular pathology in dementia. Neurology, 78(14), 1043–1050.  https://doi.org/10.1212/WNL.0b013e31824e8e7fCrossRefPubMedPubMedCentralGoogle Scholar
  29. Doets, E. L., van Wijngaarden, J. P., Szczecińska, A., Dullemeijer, C., Souverein, O. W., Dhonukshe-Rutten, R. A. M., … de Groot, L. C. P. G. M. (2013). Vitamin B12 intake and status and cognitive function in elderly people. Epidemiologic Reviews, 35, 2–21.  https://doi.org/10.1093/epirev/mxs003CrossRefPubMedGoogle Scholar
  30. Dugbartey, A. T. (1998). Neurocognitive aspects of hypothyroidism. Archives of Internal Medicine, 158(13), 1413–1418.  https://doi.org/10.1001/archinte.158.13.1413CrossRefPubMedGoogle Scholar
  31. Ejaz, S. M., Khawaja, I. S., Bhatia, S., & Hurwitz, T. D. (2011). Obstructive sleep apnea and depression. Innovations in Clinical Neuroscience, 8(8), 17–25.PubMedPubMedCentralGoogle Scholar
  32. Etgen, T., Sander, D., Bickel, H., & Förstl, H. (2011). Mild cognitive impairment and dementia: The importance of modifiable risk factors. Deutsches Arzteblatt International, 108(44), 743–750.  https://doi.org/10.3238/arztebl.2011.0743CrossRefPubMedPubMedCentralGoogle Scholar
  33. Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A., Mayeux, R., … van Duijn, C. M. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA, 278(16), 1349–1356.CrossRefGoogle Scholar
  34. Fei, K., Rodriguez-Lopez, J. S., Ramos, M., Islam, N., Trinh-Shevrin, C., Yi, S. S., … Thorpe, L. E. (2017). Racial and ethnic subgroup disparities in hypertension prevalence, New York City health and nutrition examination survey, 2013–2014. Preventing Chronic Disease, 14.  https://doi.org/10.5888/pcd14.160478
  35. Fitten, L. J., Ortiz, F., Fairbanks, L., Bartzokis, G., Lu, P., Klein, E., … Ringman, J. (2014). Younger age of dementia diagnosis in a Hispanic population in southern California. International Journal of Geriatric Psychiatry, 29(6), 586–593.  https://doi.org/10.1002/gps.4040CrossRefPubMedPubMedCentralGoogle Scholar
  36. Fitten, L. J., Ortiz, F., & Pontón, M. (2001). Frequency of Alzheimer’s disease and other dementias in a community outreach sample of Hispanics. Journal of the American Geriatrics Society, 49(10), 1301–1308.CrossRefPubMedPubMedCentralGoogle Scholar
  37. Forouzanfar, M. H., Liu, P., Roth, G. A., Ng, M., Biryukov, S., Marczak, L., … Murray, C. J. L. (2017). Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA, 317(2), 165–182.  https://doi.org/10.1001/jama.2016.19043CrossRefPubMedPubMedCentralGoogle Scholar
  38. Franciscus, A. (2014). Hepatitis C and U.S. Hispanics. Retrieved from https://npin.cdc.gov/publication/hcsp-fact-sheet-hepatitis-c-and-us-hispanics
  39. Gan, E. H., & Pearce, S. H. S. (2012). Clinical review: The thyroid in mind: Cognitive function and low thyrotropin in older people. The Journal of Clinical Endocrinology and Metabolism, 97(10), 3438–3449.  https://doi.org/10.1210/jc.2012-2284CrossRefPubMedPubMedCentralGoogle Scholar
  40. Ganguli, M. (2009). Depression, cognitive impairment and dementia: Why should clinicians care about the web of causation? Indian Journal of Psychiatry, 51(Suppl 1), S29–S34.PubMedPubMedCentralGoogle Scholar
  41. Garrod, M. G., Green, R., Allen, L. H., Mungas, D. M., Jagust, W. J., Haan, M. N., & Miller, J. W. (2008). Fraction of total plasma vitamin B12 bound to transcobalamin correlates with cognitive function in elderly Latinos with depressive symptoms. Clinical Chemistry, 54(7), 1210–1217.  https://doi.org/10.1373/clinchem.2007.102632CrossRefPubMedPubMedCentralGoogle Scholar
  42. Gąsecki, D., Kwarciany, M., Nyka, W., & Narkiewicz, K. (2013). Hypertension, brain damage and cognitive decline. Current Hypertension Reports, 15(6), 547–558.  https://doi.org/10.1007/s11906-013-0398-4CrossRefPubMedPubMedCentralGoogle Scholar
  43. González, H. M., Haan, M. N., & Hinton, L. (2001). Acculturation and the prevalence of depression in older Mexican Americans: Baseline results of the Sacramento Area Latino Study on Aging. Journal of the American Geriatrics Society, 49(7), 948–953.CrossRefGoogle Scholar
  44. González-Rodríguez, L. A., Felici-Giovanini, M. E., & Haddock, L. (2013). Thyroid dysfunction in an adult female population: A population-based study of Latin American Vertebral Osteoporosis Study (LAVOS) - Puerto Rico site. Puerto Rico Health Sciences Journal, 32(2), 57–62.PubMedPubMedCentralGoogle Scholar
  45. Gorelick, P. B., Scuteri, A., Black, S. E., Decarli, C., Greenberg, S. M., Iadecola, C., … American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. (2011). Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the american heart association/american stroke association. Stroke, 42(9), 2672–2713.  https://doi.org/10.1161/STR.0b013e3182299496CrossRefPubMedPubMedCentralGoogle Scholar
  46. Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., … Grossman, M. (2011). Classification of primary progressive aphasia and its variants. Neurology, 76(11), 1006–1014.  https://doi.org/10.1212/WNL.0b013e31821103e6CrossRefPubMedPubMedCentralGoogle Scholar
  47. Griswold, K. S., Del Regno, P. A., & Berger, R. C. (2015). Recognition and differential diagnosis of psychosis in primary care. American Family Physician, 91(12), 856–863.PubMedGoogle Scholar
  48. Gurland, B. J., Wilder, D. E., Lantigua, R., Stern, Y., Chen, J., Killeffer, E. H., & Mayeux, R. (1999). Rates of dementia in three ethnoracial groups. International Journal of Geriatric Psychiatry, 14(6), 481–493.CrossRefGoogle Scholar
  49. Haan, M. N., Miller, J. W., Aiello, A. E., Whitmer, R. A., Jagust, W. J., Mungas, D. M., … Green, R. (2007). Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: Results from the Sacramento Area Latino Study on Aging. The American Journal of Clinical Nutrition, 85(2), 511–517.CrossRefPubMedPubMedCentralGoogle Scholar
  50. Haan, M. N., Mungas, D. M., Gonzalez, H. M., Ortiz, T. A., Acharya, A., & Jagust, W. J. (2003). Prevalence of dementia in older latinos: The influence of type 2 diabetes mellitus, stroke and genetic factors. Journal of the American Geriatrics Society, 51(2), 169–177.CrossRefGoogle Scholar
  51. Hardy, D. J., & Vance, D. E. (2009). The neuropsychology of HIV/AIDS in older adults. Neuropsychology Review, 19(2), 263–272.  https://doi.org/10.1007/s11065-009-9087-0CrossRefPubMedGoogle Scholar
  52. Heaton, R. K., Ryan, L., & Grant, I. (2009). Demographic influences and use of demographically corrected norms in neuropsychological assessment. In I. Grant & K. M. Adams (Eds.), Neuropsychological assessment of neuropsychiatric and neuromedical disorders (3rd ed., pp. 127–157). New York, NY: Oxford University Press.Google Scholar
  53. Heinrich, T. W., & Grahm, G. (2003). Hypothyroidism presenting as psychosis: Myxedema madness revisited. Primary Care Companion to The Journal of Clinical Psychiatry, 5(6), 260–266.CrossRefPubMedPubMedCentralGoogle Scholar
  54. Hinds, H. E., Johnson, A. A., Webb, M. C., & Graham, A. P. (2011). Iron, folate, and vitamin B12 status in the elderly by gender and ethnicity. Journal of the National Medical Association, 103(9–10), 870–877.CrossRefGoogle Scholar
  55. Hinton, C. F., Harris, K. B., Borgfeld, L., Drummond-Borg, M., Eaton, R., Lorey, F., … Pass, K. A. (2010). Trends in incidence rates of congenital hypothyroidism related to select demographic factors: Data from the United States, California, Massachusetts, New York, and Texas. Pediatrics, 125(Supplement 2), S37–S47.  https://doi.org/10.1542/peds.2009-1975DCrossRefPubMedGoogle Scholar
  56. Horowitz, C. R., Colson, K. A., Herbert, P. L., & Lancaster, K. (2004). Barriers to buying healthy foods for people with diabetes: Evidence of environmental disparities. American Journal of Public Health, 94(9), 1549–1554.  https://doi.org/10.2105/ajph.94.9.1549CrossRefPubMedPubMedCentralGoogle Scholar
  57. Huckans, M., Seelye, A., Parcel, T., Mull, L., Woodhouse, J., Bjornson, D., … Hauser, P. (2009). The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder. Journal of the International Neuropsychological Society, 15(01), 69.  https://doi.org/10.1017/S1355617708090085CrossRefPubMedPubMedCentralGoogle Scholar
  58. Iadecola, C. (2013). The pathobiology of vascular dementia. Neuron, 80(4), 844–866.  https://doi.org/10.1016/j.neuron.2013.10.008CrossRefPubMedGoogle Scholar
  59. Irwin, J., & Terrault, N. (2008). Cognitive impairment in hepatitis C patients on antiviral therapy. Gastroenterology & Hepatology, 4(1), 65–67.Google Scholar
  60. Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., … Trojanowski, J. Q. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. The Lancet. Neurology, 9(1), 119–128.  https://doi.org/10.1016/S1474-4422(09)70299-6CrossRefPubMedPubMedCentralGoogle Scholar
  61. Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., … Tournier-Lasserve, E. (1996). Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature, 383(6602), 707–710.  https://doi.org/10.1038/383707a0CrossRefPubMedGoogle Scholar
  62. Kang, H., Zhao, F., You, L., Giorgetta, C., Venkatesh, D., Sarkhel, S., & Prakash, R. (2014). Pseudo- dementia: A neuropsychological review. Annals of Indian Academy of Neurology, 17(2), 147–154.  https://doi.org/10.4103/0972-2327.132613CrossRefPubMedPubMedCentralGoogle Scholar
  63. Kirk, J. K., Passmore, L. V., Bell, R. A., Narayan, K. M. V., D’Agostino, R. B., Arcury, T. A., & Quandt, S. A. (2008). Disparities in A1C levels between Hispanic and non-Hispanic white adults with diabetes: A meta-analysis. Diabetes Care, 31(2), 240–246.  https://doi.org/10.2337/dc07-0382CrossRefPubMedGoogle Scholar
  64. Kodl, C. T., & Seaquist, E. R. (2008). Cognitive dysfunction and diabetes mellitus. Endocrine Reviews, 29(4), 494–511.  https://doi.org/10.1210/er.2007-0034CrossRefPubMedPubMedCentralGoogle Scholar
  65. Kopelman, M. D. (2015). What does a comparison of the alcoholic Korsakoff syndrome and thalamic infarction tell us about thalamic amnesia? Neuroscience & Biobehavioral Reviews, 54, 46–56.  https://doi.org/10.1016/j.neubiorev.2014.08.014CrossRefGoogle Scholar
  66. Kuniholm, M. H., Jung, M., Everhart, J. E., Cotler, S., Heiss, G., McQuillan, G., … Ho, G. Y. F. (2014). Prevalence of hepatitis C virus infection in US Hispanic/Latino adults: Results from the NHANES 2007-2010 and HCHS/SOL studies. The Journal of Infectious Diseases, 209(10), 1585–1590.  https://doi.org/10.1093/infdis/jit672CrossRefPubMedPubMedCentralGoogle Scholar
  67. Kwan, L. L., Bermudez, O. I., & Tucker, K. L. (2002). Low vitamin B-12 intake and status are more prevalent in Hispanic older adults of Caribbean origin than in neighborhood- matched non-Hispanic whites. The Journal of Nutrition, 132(7), 2059–2064.CrossRefGoogle Scholar
  68. Lezak, M. D., Howieson, D. B., Bigler, E. D., & Tranel, D. (2012). Neuropsychological assessment (5th ed.). New York, NY: Oxford University Press.Google Scholar
  69. Lin, K.-H., Lin, H.-Z., Lin, Y.-P., Meng, F.-C., Lin, F., Wu, H.-T., & Lin, G.-M. (2017). Obstructive sleep apnea and retinal microvascular characteristics: A brief review. Neuropsychiatry, 7(1), 12–21.  https://doi.org/10.4172/Neuropsychiatry.1000173CrossRefGoogle Scholar
  70. Lista, S., Dubois, B., & Hampel, H. (2015). Paths to Alzheimer’s disease prevention: From modifiable risk factors to biomarker enrichment strategies. The Journal of Nutrition, Health & Aging, 19(2), 154–163.  https://doi.org/10.1007/s12603-014-0515-3CrossRefGoogle Scholar
  71. Livney, M. G., Clark, C. M., Karlawish, J. H., Cartmell, S., Negrón, M., Nuñez, J., … Arnold, S. E. (2011). Ethnoracial differences in the clinical characteristics of Alzheimer’s disease at initial presentation at an urban Alzheimer’s disease center. The American Journal of Geriatric Psychiatry, 19(5), 430–439.  https://doi.org/10.1097/JGP.0b013e3181f7d881CrossRefPubMedPubMedCentralGoogle Scholar
  72. Lora, C. M., Daviglus, M. L., Kusek, J. W., Porter, A., Ricardo, A. C., Go, A. S., & Lash, J. P. (2009). Chronic kidney disease in United States Hispanics: A growing public health problem. Ethnicity & Disease, 19(4), 466–472.Google Scholar
  73. Loredo, J. S., Soler, X., Bardwell, W., Ancoli-Israel, S., Dimsdale, J. E., & Palinkas, L. A. (2010). Sleep health in U.S. Hispanic population. Sleep, 33(7), 996–997.CrossRefGoogle Scholar
  74. Luber, S. D., Brady, W. J., Brand, A., Young, J., Guertler, A. T., & Kefer, M. (1996). Acute hypoglycemia masquerading as head trauma: A report of four cases. The American Journal of Emergency Medicine, 14(6), 543–547.  https://doi.org/10.1016/S0735-6757(96)90094-7CrossRefPubMedGoogle Scholar
  75. Luchsinger, J. A. (2012). Type 2 diabetes and cognitive impairment: Linking mechanisms. Journal of Alzheimer’s Disease: JAD, 30(Suppl 2), S185–S198.  https://doi.org/10.3233/JAD-2012-111433CrossRefPubMedGoogle Scholar
  76. Lustman, P. J., & Clouse, R. E. (2005). Depression in diabetic patients: The relationship between mood and glycemic control. Journal of Diabetes and its Complications, 19(2), 113–122.  https://doi.org/10.1016/j.jdiacomp.2004.01.002CrossRefPubMedGoogle Scholar
  77. Macey, P. M. (2012). Is brain injury in obstructive sleep apnea reversible? Sleep, 35(1), 9–10.  https://doi.org/10.5665/sleep.1572CrossRefPubMedPubMedCentralGoogle Scholar
  78. Magreni, A., Bann, D. V., Schubart, J. R., & Goldenberg, D. (2015). The effects of race and ethnicity on thyroid cancer incidence. JAMA Otolaryngology – Head & Neck Surgery, 141(4), 319–323.  https://doi.org/10.1001/jamaoto.2014.3740CrossRefGoogle Scholar
  79. Martin, P. R., Singleton, C. K., & Hiller-Sturmhöfel, S. (2003). The role of thiamine deficiency in alcoholic brain disease. Alcohol Research & Health: The Journal of the National Institute on Alcohol Abuse and Alcoholism, 27, 134–142.Google Scholar
  80. Matthews, K. D., & Richter, R. W. (2003). Binswanger’s disease: Its association with hypertension and obstructive sleep apnea. The Journal of the Oklahoma State Medical Association, 96(6), 265–268; quiz 269–270.PubMedGoogle Scholar
  81. McCutchan, J. A., Wu, J. W., Robertson, K., Koletar, S. L., Ellis, R. J., Cohn, S., … Williams, P. L. (2007). HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS, 21(9), 1109–1117.  https://doi.org/10.1097/QAD.0b013e3280ef6acdCrossRefPubMedGoogle Scholar
  82. McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., … Kosaka, K. (2017). Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology, 89(1), 88–100.  https://doi.org/10.1212/WNL.0000000000004058CrossRefPubMedPubMedCentralGoogle Scholar
  83. McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O’Brien, J. T., Feldman, H., … Consortium on DLB. (2005). Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology, 65(12), 1863–1872.  https://doi.org/10.1212/01.wnl.0000187889.17253.b1CrossRefPubMedPubMedCentralGoogle Scholar
  84. McKhann, G. M., Albert, M. S., Grossman, M., Miller, B., Dickson, D., Trojanowski, J. Q., & Work Group on Frontotemporal Dementia and Pick’s Disease. (2001). Clinical and pathological diagnosis of frontotemporal dementia: Report of the work group on Frontotemporal Dementia and Pick’s Disease. Archives of Neurology, 58(11), 1803–1809.CrossRefGoogle Scholar
  85. McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., … Phelps, C. H. (2011). The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 7(3), 263–269.  https://doi.org/10.1016/j.jalz.2011.03.005CrossRefGoogle Scholar
  86. McLeod, D. S. A., Caturegli, P., Cooper, D. S., Matos, P. G., & Hutfless, S. (2014). Variation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel. JAMA, 311(15), 1563–1565.  https://doi.org/10.1001/jama.2013.285606CrossRefPubMedGoogle Scholar
  87. McNay, E. C., & Cotero, V. E. (2010). Mini-review: Impact of recurrent hypoglycemia on cognitive and brain function. Physiology & Behavior, 100(3), 234–238.  https://doi.org/10.1016/j.physbeh.2010.01.004CrossRefGoogle Scholar
  88. Mendez, M. F. (2012). Early-onset Alzheimer’s disease: Nonamnestic subtypes and type 2 AD. Archives of Medical Research, 43(8), 677–685.  https://doi.org/10.1016/j.arcmed.2012.11.009CrossRefPubMedPubMedCentralGoogle Scholar
  89. Miller, J. W., Green, R., Ramos, M. I., Allen, L. H., Mungas, D. M., Jagust, W. J., & Haan, M. N. (2003). Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging. The American Journal of Clinical Nutrition, 78(3), 441–447.CrossRefGoogle Scholar
  90. Miller-Thomas, M. M., Sipe, A. L., Benzinger, T. L. S., McConathy, J., Connolly, S., & Schwetye, K. E. (2016). Multimodality review of amyloid-related diseases of the central nervous system. Radiographics, 36(4), 1147–1163.  https://doi.org/10.1148/rg.2016150172CrossRefPubMedPubMedCentralGoogle Scholar
  91. Monaco, S., Mariotto, S., Ferrari, S., Calabrese, M., Zanusso, G., Gajofatto, A., … Dammacco, F. (2015). Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015. World Journal of Gastroenterology, 21(42), 11974–11983.  https://doi.org/10.3748/wjg.v21.i42.11974CrossRefPubMedPubMedCentralGoogle Scholar
  92. Moreton, F. C., Razvi, S. S. M., Davidson, R., & Muir, K. W. (2014). Changing clinical patterns and increasing prevalence in CADASIL. Acta Neurologica Scandinavica, 130(3), 197–203.  https://doi.org/10.1111/ane.12266CrossRefPubMedGoogle Scholar
  93. Moretti, R., Torre, P., Antonello, R. M., Cattaruzza, T., Cazzato, G., & Bava, A. (2004). Vitamin B12 and folate depletion in cognition: A review. Neurology India, 52(3), 310–318.PubMedGoogle Scholar
  94. Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., … Benson, D. F. (1998). Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology, 51(6), 1546–1554.CrossRefGoogle Scholar
  95. Nervi, A., Reitz, C., Tang, M.-X., Santana, V., Piriz, A., Reyes, D., … Mayeux, R. (2011). Familial aggregation of dementia with Lewy bodies. Archives of Neurology, 68(1), 90–93.  https://doi.org/10.1001/archneurol.2010.319CrossRefPubMedPubMedCentralGoogle Scholar
  96. Nwankwo, T., Yoon, S. S., Burt, V., & Gu, Q. (2013). Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief, 133, 1–8.Google Scholar
  97. O’Brien, J. T., Erkinjuntti, T., Reisberg, B., Roman, G., Sawada, T., Pantoni, L., … DeKosky, S. T. (2003). Vascular cognitive impairment. The Lancet. Neurology, 2(2), 89–98.CrossRefGoogle Scholar
  98. O’Brien, J. T., & Thomas, A. (2015). Vascular dementia. The Lancet, 386(10004), 1698–1706.  https://doi.org/10.1016/S0140-6736(15)00463-8CrossRefGoogle Scholar
  99. Obisesan, T. O. (2009). Hypertension and cognitive function. Clinics in Geriatric Medicine, 25(2), 259–288.  https://doi.org/10.1016/j.cger.2009.03.002CrossRefPubMedPubMedCentralGoogle Scholar
  100. Onyike, C. U., & Diehl-Schmid, J. (2013). The epidemiology of frontotemporal dementia. International Review of Psychiatry, 25(2), 130–137.  https://doi.org/10.3109/09540261.2013.776523CrossRefPubMedGoogle Scholar
  101. Oscar-Berman, M., & Marinković, K. (2007). Alcohol: Effects on neurobehavioral functions and the brain. Neuropsychology Review, 17(3), 239–257.  https://doi.org/10.1007/s11065-007-9038-6CrossRefPubMedPubMedCentralGoogle Scholar
  102. Pabon-Nau, L. P., Cohen, A., Meigs, J. B., & Grant, R. W. (2010). Hypertension and diabetes prevalence among U.S. Hispanics by country of origin: The National Health Interview Survey 2000–2005. Journal of General Internal Medicine, 25(8), 847–852.  https://doi.org/10.1007/s11606-010-1335-8CrossRefPubMedPubMedCentralGoogle Scholar
  103. Palloni, A., & Arias, E. (2004). Paradox lost: Explaining the hispanic adult mortality advantage. Demography, 41(3), 385–415.  https://doi.org/10.1353/dem.2004.0024CrossRefPubMedGoogle Scholar
  104. Parsons, T. D., Braaten, A. J., Hall, C. D., & Robertson, K. R. (2006). Better quality of life with neuropsychological improvement on HAART. Health and Quality of Life Outcomes, 4, 11.  https://doi.org/10.1186/1477-7525-4-11CrossRefPubMedPubMedCentralGoogle Scholar
  105. Rabinovici, G. D., & Miller, B. L. (2010). Frontotemporal lobar degeneration: Epidemiology, pathophysiology, diagnosis and management. CNS Drugs, 24(5), 375–398.  https://doi.org/10.2165/11533100-000000000-00000CrossRefPubMedPubMedCentralGoogle Scholar
  106. Rabinovici, G. D., Seeley, W. W., Kim, E. J., Gorno-Tempini, M. L., Rascovsky, K., Pagliaro, T. A., … Rosen, H. J. (2007). Distinct MRI atrophy patterns in autopsy-proven Alzheimer’s disease and frontotemporal lobar degeneration. American Journal of Alzheimer’s Disease and Other Dementias, 22(6), 474–488.  https://doi.org/10.1177/1533317507308779CrossRefPubMedPubMedCentralGoogle Scholar
  107. Ramos, A. R., Tarraf, W., Rundek, T., Redline, S., Wohlgemuth, W. K., Loredo, J. S., … González, H. M. (2015). Obstructive sleep apnea and neurocognitive function in a Hispanic/Latino population. Neurology, 84(4), 391–398.  https://doi.org/10.1212/WNL.0000000000001181CrossRefPubMedPubMedCentralGoogle Scholar
  108. Ramos, M. I., Allen, L. H., Mungas, D. M., Jagust, W. J., Haan, M. N., Green, R., & Miller, J. W. (2005). Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging. The American Journal of Clinical Nutrition, 82(6), 1346–1352.CrossRefGoogle Scholar
  109. Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., … Miller, B. L. (2011). Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain: A Journal of Neurology, 134(Pt 9), 2456–2477.  https://doi.org/10.1093/brain/awr179CrossRefGoogle Scholar
  110. Raz, N., Yang, Y. Q., Rodrigue, K. M., Kennedy, K. M., Lindenberger, U., & Ghisletta, P. (2012). White matter deterioration in 15 months: Latent growth curve models in healthy adults. Neurobiology of Aging, 33(2), 429.e1–429.e5.  https://doi.org/10.1016/j.neurobiolaging.2010.11.018CrossRefGoogle Scholar
  111. Redline, S., Sotres-Alvarez, D., Loredo, J., Hall, M., Patel, S. R., Ramos, A., … Daviglus, M. L. (2014). Sleep-disordered breathing in Hispanic/Latino individuals of diverse backgrounds. The Hispanic Community Health Study/Study of Latinos. American Journal of Respiratory and Critical Care Medicine, 189(3), 335–344.  https://doi.org/10.1164/rccm.201309-1735OCCrossRefPubMedPubMedCentralGoogle Scholar
  112. Resta, F., Triggiani, V., Barile, G., Benigno, M., Suppressa, P., Giagulli, V. A., … Sabbà, C. (2012). Subclinical hypothyroidism and cognitive dysfunction in the elderly. Endocrine, Metabolic & Immune Disorders Drug Targets, 12(3), 260–267.CrossRefGoogle Scholar
  113. Reynolds, E. H. (2002). Folic acid, ageing, depression, and dementia. BMJ: British Medical Journal, 324(7352), 1512–1515.CrossRefGoogle Scholar
  114. Ríos-Bedoya, C. F., & Freile-Salinas, D. (2014). Incidence of alcohol use disorders among Hispanic subgroups in the USA. Alcohol and Alcoholism (Oxford, Oxfordshire), 49(5), 549–556.  https://doi.org/10.1093/alcalc/agu032CrossRefGoogle Scholar
  115. Rivera Mindt, M., Byrd, D., Saez, P., & Manly, J. (2010). Increasing culturally competent neuropsychological services for ethnic minority populations: A call to action. The Clinical Neuropsychologist, 24(3), 429–453.  https://doi.org/10.1080/13854040903058960CrossRefPubMedGoogle Scholar
  116. Rizzi, L., Rosset, I., & Roriz-Cruz, M. (2014). Global epidemiology of dementia: Alzheimer’s and vascular types. BioMed Research International, 2014.  https://doi.org/10.1155/2014/908915
  117. Rodríguez-Torres, M., Ríos-Bedoya, C. F., Ortiz-Lasanta, G., Marxuach-Cuétara, A. M., & Jiménez-Rivera, J. (2008). Thyroid dysfunction (TD) among chronic hepatitis C patients with mild and severe hepatic fibrosis. Annals of Hepatology, 7(1), 72–77.CrossRefGoogle Scholar
  118. Russell, D., & Taylor, J. (2009). Living alone and depressive symptoms: The influence of gender, physical disability, and social support among Hispanic and non-Hispanic older adults. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 64B(1), 95–104.  https://doi.org/10.1093/geronb/gbn002CrossRefGoogle Scholar
  119. Sahoo, S., Mehra, A., & Grover, S. (2016). Acute hyperglycemia associated with psychotic symptoms in a patient with Type 1 Diabetes Mellitus: A case report. Innovations in Clinical Neuroscience, 13(11–12), 25–27.PubMedPubMedCentralGoogle Scholar
  120. Salazar, R., Royall, D. R., & Palmer, R. F. (2015). Neuropsychiatric symptoms in community- dwelling Mexican-Americans: Results from the Hispanic Established Population for Epidemiological Study of the Elderly (HEPESE) study. International Journal of Geriatric Psychiatry, 30, 300–307.  https://doi.org/10.1002/gps.4141CrossRefPubMedGoogle Scholar
  121. Samuels, M. H. (2008). Cognitive function in untreated hypothyroidism and hyperthyroidism. Current Opinion in Endocrinology, Diabetes, and Obesity, 15(5), 429–433.  https://doi.org/10.1097/MED.0b013e32830eb84cCrossRefPubMedGoogle Scholar
  122. Sands-Lincoln, M., Grandner, M., Whinnery, J., Keenan, B. T., Jackson, N., & Gurubhagavatula, I. (2013). The association between obstructive sleep apnea and hypertension by race/ethnicity in a nationally representative sample. The Journal of Clinical Hypertension, 15(8), 593–599.  https://doi.org/10.1111/jch.12144CrossRefPubMedGoogle Scholar
  123. Savica, R., Grossardt, B. R., Bower, J. H., Boeve, B. F., Ahlskog, J. E., & Rocca, W. A. (2014). Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurology, 70(11), 1396–1402.  https://doi.org/10.1001/jamaneurol.2013.3579CrossRefGoogle Scholar
  124. Senzolo, M., Schiff, S., D’Aloiso, C. M., Crivellin, C., Cholongitas, E., Burra, P., & Montagnese, S. (2011). Neuropsychological alterations in hepatitis C infection: The role of inflammation. World Journal of Gastroenterology, 17(29), 3369.  https://doi.org/10.3748/wjg.v17.i29.3369CrossRefPubMedPubMedCentralGoogle Scholar
  125. Shanmugarajah, P. D., Hoggard, N., Currie, S., Aeschlimann, D. P., Aeschlimann, P. C., Gleeson, D. C., … Hadjivassiliou, M. (2016). Alcohol-related cerebellar degeneration: Not all down to toxicity? Cerebellum & Ataxias, 3, 17.  https://doi.org/10.1186/s40673-016-0055-1CrossRefGoogle Scholar
  126. Singer, E. J., & Thames, A. D. (2016). Neurobehavioral manifestations of human immunodeficiency virus/AIDS. Neurologic Clinics, 34(1), 33–53.Google Scholar
  127. Sommerfield, A. J., Deary, I. J., & Frier, B. M. (2004). Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diabetes Care, 27(10), 2335–2340.CrossRefGoogle Scholar
  128. Starr, V. L., & Convit, A. (2007). Diabetes, sugar-coated but harmful to the brain. Current Opinion in Pharmacology, 7(6), 638–642.  https://doi.org/10.1016/j.coph.2007.10.007CrossRefPubMedPubMedCentralGoogle Scholar
  129. Stranks, E. K., & Crowe, S. F. (2016). The cognitive effects of obstructive sleep apnea: An updated meta-analysis. Archives of Clinical Neuropsychology, 31(2), 186–193.  https://doi.org/10.1093/arclin/acv087CrossRefPubMedGoogle Scholar
  130. Substance Abuse and Mental Health Services Administration [SAMHSA]. (2013). Hispanic subgroups differ in rates of substance use treatment need and receipt. National survey on drug use and Health (NSDUH) Report, October 24, 2013. Retrieved from http://www.samhsa.gov/data/sites/default/files/spot128-hispanic-treatment-2013/spot128-hispanic-treatment-2013.pdf
  131. Tang, M. X., Cross, P., Andrews, H., Jacobs, D. M., Small, S., Bell, K., … Mayeux, R. (2001). Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology, 56(1), 49–56.CrossRefGoogle Scholar
  132. Tang, M. X., Stern, Y., Marder, K., Bell, K., Gurland, B., Lantigua, R., … Mayeux, R. (1998). The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA, 279(10), 751–755.CrossRefGoogle Scholar
  133. Taylor, W. D. (2014). Depression in the elderly. New England Journal of Medicine, 371(13), 1228–1236.  https://doi.org/10.1056/NEJMcp1402180CrossRefPubMedGoogle Scholar
  134. Tzourio, C. (2007). Hypertension, cognitive decline, and dementia: an epidemiological perspective. Dialogues in Clinical Neuroscience, 9(1), 61–70.PubMedPubMedCentralGoogle Scholar
  135. U.S. Census Bureau. (2015). American Community Survey B03001 1-Year estimates: Hispanic or Latino origin by specific origin. Retrieved September 22, 2016.Google Scholar
  136. Vasconcellos, L. F. R., & Pereira, J. S. (2015). Parkinson’s disease dementia: Diagnostic criteria and risk factor review. Journal of Clinical and Experimental Neuropsychology, 37(9), 988–993.  https://doi.org/10.1080/13803395.2015.1073227CrossRefPubMedGoogle Scholar
  137. Vega, W. A., Rodriguez, M. A., & Gruskin, E. (2009). Health disparities in the Latino population. Epidemiologic Reviews, 31, 99–112.  https://doi.org/10.1093/epirev/mxp008CrossRefPubMedPubMedCentralGoogle Scholar
  138. Viña, J., & Lloret, A. (2010). Why women have more Alzheimer’s disease than men: Gender and mitochondrial toxicity of amyloid-beta peptide. Journal of Alzheimer’s Disease: JAD, 20(Suppl 2), S527–S533.  https://doi.org/10.3233/JAD-2010-100501CrossRefPubMedGoogle Scholar
  139. Waclawski, E. R. (2012). Hyperglycaemia and cognitive function – acute and chronic effects and work. Occupational Medicine (Oxford, England), 62(4), 236–237.  https://doi.org/10.1093/occmed/kqs017CrossRefGoogle Scholar
  140. Walker, Z., Possin, K. L., Boeve, B. F., & Aarsland, D. (2015). Lewy body dementias. The Lancet, 386(10004), 1683–1697.  https://doi.org/10.1016/S0140-6736(15)00462-6CrossRefGoogle Scholar
  141. Wang, C. (2013). The relationship between type 2 diabetes mellitus and related thyroid diseases. Journal of Diabetes Research, 2013.  https://doi.org/10.1155/2013/390534
  142. Warren, R. E., & Frier, B. M. (2005). Hypoglycaemia and cognitive function. Diabetes, Obesity and Metabolism, 7(5), 493–503.  https://doi.org/10.1111/j.1463-1326.2004.00421.xCrossRefPubMedGoogle Scholar
  143. Wen, X., Wang, N., Liu, J., Yan, Z., & Xin, Z. (2012). Detection of cognitive impairment in p atients with obstructive sleep apnea hypopnea syndrome using mismatch negativity. Neural Regeneration Research, 7(20), 1591–1598.  https://doi.org/10.3969/j.issn.1673-5374.2012.20.010CrossRefPubMedPubMedCentralGoogle Scholar
  144. Wenk, G. L. (2003). Neuropathologic changes in Alzheimer’s disease. The Journal of Clinical Psychiatry, 64(Suppl 9), 7–10.PubMedGoogle Scholar
  145. Woods, S. P., Moore, D. J., Weber, E., & Grant, I. (2009). Cognitive neuropsychology of HIV- associated neurocognitive disorders. Neuropsychology Review, 19(2), 152–168.  https://doi.org/10.1007/s11065-009-9102-5CrossRefPubMedPubMedCentralGoogle Scholar
  146. Wu, J. H., Haan, M. N., Liang, J., Ghosh, D., Gonzalez, H. M., & Herman, W. H. (2003). Diabetes as a predictor of change in functional status among older Mexican Americans: A population-based cohort study. Diabetes Care, 26(2), 314–319.CrossRefGoogle Scholar
  147. Yong, A. W., Morris, Z., Shuler, K., Smith, C., & Wardlaw, J. (2012). Acute symptomatic hypoglycaemia mimicking ischaemic stroke on imaging: A systemic review. BMC Neurology, 12, 139.  https://doi.org/10.1186/1471-2377-12-139CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2020

Authors and Affiliations

  1. 1.University of Massachusetts BostonBostonUSA
  2. 2.Bedford Veterans Hospital, Center for Translational Cognitive NeuroscienceBoston University School of MedicineBostonUSA

Personalised recommendations